Literature DB >> 10189516

Changing patterns of illicit substance use among schizophrenic patients: 1984-1996.

A A Patkar1, R C Alexander, A Lundy, K M Certa.   

Abstract

Over 1,700 psychiatric emergency room visits of schizophrenic and schizoaffective patients between 1984 and 1996 were reviewed, and urine drug screens (UDS) were recorded. Illicit drug use increased significantly over the 12-year period, with a large increase for cocaine (0% to 73% of positive UDS), a decline for amphetamines (60% to 0%), and a small increase for marijuana (0% to 27%). Opiate and sedative use remained unchanged. The results support the impression that cocaine use increased dramatically among urban schizophrenic patients beginning in 1988 and continuing to the present. Furthermore, cocaine seems to have replaced amphetamines as the preferred drug of abuse among schizophrenic persons following the crack epidemic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189516     DOI: 10.1080/105504999306090

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  4 in total

1.  The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.

Authors:  Robert R Conley; Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Bruce J Kinon
Journal:  Schizophr Res       Date:  2006-11-15       Impact factor: 4.939

Review 2.  Substance misuse in patients with schizophrenia: epidemiology and management.

Authors:  David J Kavanagh; John McGrath; John B Saunders; Glenys Dore; Dianne Clark
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

4.  Substance Use Patterns and Schizophrenia Spectrum Disorders: A Retrospective Study of Inpatients at a Community Teaching Hospital.

Authors:  Terence Tumenta; Oluwatoyin Oladeji; Manpreet Gill; Basim Ahmed Khan; Olaniyi Olayinka; Chiedozie Ojimba; Tolulope Olupona
Journal:  J Clin Med Res       Date:  2020-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.